Greenhaven Associates Inc. Cuts Position in Genpact Limited (NYSE:G)

Greenhaven Associates Inc. reduced its holdings in Genpact Limited (NYSE:G - Free Report) by 88.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 146,678 shares of the business services provider's stock after selling 1,083,660 shares during the quarter. Genpact makes up about 0.1% of Greenhaven Associates Inc.'s portfolio, making the stock its 15th largest holding. Greenhaven Associates Inc. owned about 0.08% of Genpact worth $7,390,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its position in Genpact by 8.7% during the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after purchasing an additional 441 shares during the period. KBC Group NV bought a new position in Genpact during the fourth quarter worth $298,000. State of New Jersey Common Pension Fund D acquired a new position in Genpact in the fourth quarter valued at $2,030,000. Pictet Asset Management Holding SA bought a new stake in Genpact during the fourth quarter valued at $921,000. Finally, Proficio Capital Partners LLC acquired a new stake in Genpact during the 4th quarter worth about $983,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Genpact

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company's stock, valued at $87,940. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Needham & Company LLC decreased their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Robert W. Baird lowered their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Finally, Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Genpact currently has an average rating of "Hold" and a consensus price target of $50.71.

Genpact Stock Down 1.0%

Shares of NYSE G traded down $0.44 during midday trading on Friday, hitting $43.02. 1,981,528 shares of the stock traded hands, compared to its average volume of 1,375,028. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The business has a 50 day moving average price of $46.76 and a two-hundred day moving average price of $47.29. The company has a market cap of $7.52 billion, a PE ratio of 15.15, a P/E/G ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. Genpact's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.73 EPS. On average, equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.